PMID: 6163354Jan 1, 1980Paper

Unusual intracytoplasmic inclusions in acute myeloblastic leukemia

American Journal of Hematology
D J WolfM W Pasmantier

Abstract

Unusual intracytoplasmic inclusions within early granulocyte precursor cells from a patient with acute myeloblastic leukemia (AML) are described. Based upon their staining characteristics and electron- and light-microscopic appearance, the inclusions are distinctly different from any previously described. The inclusions display a variety of shapes, including rectangles, squares, circles, ovals, and irregular, globular forms. Most of the inclusions are refractile and crystal-like. The possible composition of these inclusions is discussed. They are compared with inclusions previously described within leukemic and granulocytic cells.

References

Jan 1, 1972·Scandinavian Journal of Haematology·D CatovskyJ Robinson
Jan 1, 1973·Journal of Ultrastructure Research·L P McCallister, E Page

❮ Previous
Next ❯

Citations

Jun 1, 1988·Journal of Clinical Pathology·P K MacCallumI E Burton
Jan 1, 1986·Leukemia Research·A M MaddoxE J Freireich
May 1, 1986·Scandinavian Journal of Haematology·P FelmanP Coeur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.